Successful outcome of disseminated mucormycosis in a 3-year-old child suffering from acute leukaemia: the role of isavuconazole? A case report
Abstract Background The use of isavuconazole is approved for the management of invasive aspergillosis and mucormycosis, only in adults, as no paediatric pharmacology studies have been reported to date. Very few paediatric cases have been published concerning the use of isavuconazole. Amphotericin B...
Saved in:
Main Authors: | Marjorie Cornu (Author), Bénédicte Bruno (Author), Séverine Loridant (Author), Pauline Navarin (Author), Nadine François (Author), Fanny Lanternier (Author), Elisa Amzallag-Bellenger (Author), François Dubos (Author), Françoise Mazingue (Author), Boualem Sendid (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2018-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy
by: Jenks JD, et al.
Published: (2018) -
Isavuconazole Kinetic Exploration for Clinical Practice
by: Léa Darnaud, et al.
Published: (2018) -
Isavuconazole Pharmacokinetics and Pharmacodynamics in Children
by: Hirsh Elhence, et al.
Published: (2022) -
Role of isavuconazole in the treatment of invasive fungal infections
by: Wilson DT, et al.
Published: (2016) -
Isavuconazole Treatment for Invasive Fungal Infections in Pediatric Patients
by: Philippe Zimmermann, et al.
Published: (2022)